Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you for sharing your ideas and points of emphasis Extrinsic55.
Plethora of competition and things can change in the blink of an eye.
Marketing and brand exposure would be welcomed.
I wish you continued success in the real estate development field.
No shortage of cranes and dirt movers in my area.
Stay safe on the job site.
Extrinsic55,
Good morning! Thanks for being another set of eyes on Mymetics and sharing your feedback. You can relate as being a seasoned CEO yourself as to what obstacles Mr. Kempers faces on a daily, quarterly and annual basis.
What strengths do you see with Mr. Kempers from an outsider looking in as he has guided MYMX for a decade?
What opportunities have you observed?
What would you focus on long/short term if you were CEO of MYMX?
Do you ever work as a consultant?
I pride myself in R&D but haven't discovered the catalyst that you've located.
Did you wish to share your discovery?
Have a great weekend and much success to your business.
Gratitude,
Phosphene
IO Biotech hires CFO, Keith Vendola.
July 8, 2021.
"As an executive and investment banker, he has contributed to many transactions and helped companies raise over $850 million."
"Dr. Vendola will report to the chief executive officer ("CEO") and be based in the United States."
https://www.prnewswire.com/news-releases/io-biotech-strengthens-leadership-team-with-appointment-of-keith-vendola-as-chief-financial-officer-301327652.html
Exploratory project partner.
Merck entered into non-exclusive voluntary licensing agreements with five generic manufacturers in India for its oral COVID-19 antiviral therapeutic, molnupiravir, currently in phase 3 trials. The company said the agreements would accelerate the drug’s availability in India and other low- and middle-income countries once it’s approved by local regulatory authorities.
April 27,2021
https://www.fiercepharma.com/pharma/covid-19-tracker-johnson-johnson-aims-to-test-shot-kids-president-trump-talks-firing-fauci
An oral pill for COVID-19? Molnupiravir shows promise
Jun 27 2021
https://www.news-medical.net/news/20210627/An-oral-pill-for-COVID19-Molnupiravir-shows-promise.aspx
Transvac 2 project is a virosomal- based vaccine in progress by European MI Matrix Company.
Can anyone find info on European MI Matrix Company?
https://www.mymetics.com/media-center/mymetics-receives-support-virosome-based-covid-19-vaccine-development-european-vaccine-infrastructure-project-transvac2/
Dr. Toon Stegmann, Novartiz India
https://biography.omicsonline.org/switzerland/novartiz-india/toon-s-1561155
https://www.novartis.in/
Common denominator for sure.
He's also on BOD of Inthera with Nanna Lüneborg (IO Biotech cofounder).
https://monophy.com/gifs/lakings-la-kings-drew-doughty-fefNIvPYdbAorXiIV0
$1.5 billion
Just on the catalyst of oncology, allergy and hiv.
Mr. Kempers has skillfully expanded and added company value with oncology, allergy, covid19 as legs of the octopus to go along with the established malaria, hiv and influenza.
He doesn't need a homerun; just a single like he had with Astellas to get the pps moving. Then it will be in better position to reach dollar range on LOI.
His wife's work history includes Global Manufacturing Site Communications Manager for GSK. Manufacturing Communications Manager for Novartis. Currently, Director Global Communications Biosimilars for Fresenius-Kabi Biosimilars.
The Kempers family are good people and well connected.
The lack of communication is comical but I've enjoyed watching the progress of what he's built over the years.
Second generation on covid19 is the wildcard.
Fruci & Associates has to Windex those books first.
Not sure of the buyer but MYMX will be sold.
The IgM work caught their attention also.
The article is listed as “Fast Track,” indicating these new and exciting data should get special attention.
The United States’ top AIDS scientist, Dr. Anthony Fauci, called the results “very impressive” and “really striking.”
https://guardian.ng/features/promising-class-of-antibodies-protects-against-hiv-1-infection/
That was three years ago so you know its advanced since then.
Then came the work with Dr. Francois Villinger and Dr. Anthony Fauci.
https://pubmed.ncbi.nlm.nih.gov/31083697/
Hope life is good HH.
Later.
Jasper Bos joins Forbion’s Growth Fund investment team
18th May 2021
https://forbion.com/en/
Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing
TRANSVAC2, part of the EU's Horizon 2020 program, provides trainings to streamline vaccine manufacturing and development
Merck to offer its M Lab™ Collaboration Center in Molsheim, France for process development skills training
https://www.prnewswire.com/in/news-releases/merck-joins-transvac2-program-to-advance-vaccine-development-and-manufacturing-891454454.html
5. Recent progress on virosome-based vaccines for SARS-CoV-2
Transvac 2 project is a virosomal- based vaccine in progress by European MI Matrix Company.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049750/
https://www.mymetics.com/media-center/mymetics-receives-support-virosome-based-covid-19-vaccine-development-european-vaccine-infrastructure-project-transvac2/
Definitely sandbagging boss.
#3) COP-virosomes were the only synthetic therapy able to fully reverse asthma symptoms as well as lung inflammation. That was over a year ago. I'd think Stallergenes (Ernesto Bertarelli) or big pharma would scoop that up and run with it.
#4) IO Biotech's CSO was busy during 2020; coronavirus didn't slow them down. In fact they got $155 million USD in January 2021. The 10K implied nothing was accomplished in "exploratory project". https://research.regionh.dk/en/persons/mads-hald-andersen(670d0dcc-2d35-4020-b641-71dcf420b5a1)/publications.html
The January Biopole story, accountant change and squirrelly activity with 10Q and 10K is the only direct news this year.
Please share if you receive a reply from management.
Thank you.
That link luxferuttam appears to be out of India.
Might be software generated like you said.
I reached back out to Dr. Bottazzi but haven't received reply since original contact in May 2021.
Sorry for delay in response.
Had to get my miles in and release those endorphins this morning.
Have a good day friend.
The virosome pairing and science was successful Siar!
Mymetics and Baylor are seeking additional funding opportunities to start in parallel the GMP manufacturing and preparations for clinical trials to speed-up the development of a potential Covid-19 vaccine.
“This vaccine represents an urgent biotechnology innovation for ensuring health equity and combating the COVID-19 pandemic,” said Dr. Peter Hotez.
June 8, 2021.
Baylor University Covid Vaccine Development
https://luxferuttam.com/pnvzwlj/baylor-university-covid-vaccine-development
I understand your disappointment. Its all political now between big pharma, different countries and MYMX insiders to come to terms for the additional funding. Mymetics won't remain at $0.07 pps when funding is announced.
Mymetics and Baylor are seeking additional funding opportunities to start in parallel the GMP manufacturing and preparations for clinical trials to speed-up the development of a potential Covid-19 vaccine.
“This vaccine represents an urgent biotechnology innovation for ensuring health equity and combating the COVID-19 pandemic,” said Dr. Peter Hotez.
June 8, 2021.
Baylor University Covid Vaccine Development
https://luxferuttam.com/pnvzwlj/baylor-university-covid-vaccine-development
***Bottom 1/3 of article***
Dr. Mads Hald Andersen is Chief Scientific Officer & Founder at IO Biotech.
He is also Director of CCIT (Center for Cancer Immune Therapy at Herlev University Hospital.
https://theorg.com/org/io-biotech/org-chart/mads-hald-andersen
Research history indicates IO Biotech was very active in 2020 per links below.
https://patents.justia.com/inventor/mads-hald-andersen
https://research.regionh.dk/en/persons/mads-hald-andersen(670d0dcc-2d35-4020-b641-71dcf420b5a1)/publications.html
Recently, Professor Andersen initiated a brand new research program focusing on antigen-specific immune regulation, e.g. IDO and PD-L1. CCIT has finalized the first ever clinical vaccination trial based on such self-antigens with promising clinical data.
https://isim.ku.dk/staff/?pure=en/persons/354231
Conflict of interest statement on below link.
https://pubmed.ncbi.nlm.nih.gov/33408343/
Jasper Bos and Nanna Lüneborg are on the Board of Inthera Bioscience AG with Mark Krul.
https://www.biospace.com/article/releases/-b-inthera-bioscience-b-raises-eur-3-4-million-in-seed-financing-round-/
https://intherabio.com/
Nanna Lüneborg is the Investment Director at Novo Seeds and co-founder of IO Biotech.
https://www.labiotech.eu/interview/io-biotech-startup-immunotherapy/
https://www.pharmaceutical-technology.com/features/investing-in-innovative-biotechs-with-novo-ventures/
https://www.novoholdings.dk/news/
Mark Krul: https://aglaia-oncology.com/team/mark-krul/
Whomever can eradicate cancer and covid19 has my support Steel.
It appears that Dr. Gerd, Rinaldo and Amiq are involved in the work of both causes.
Inovio is going with a zapper approach which would require some form of refrigeration.
Mymetics would go with electrospray and not have a need to refrigerate (MACIVIVA).
https://spectrum.ieee.org/biomedical/devices/inovios-electrical-device-zaps-a-covid19-vaccine-into-the-body
May 26,2021.
Protein-based vaccines, which are relatively stable, are “low-hanging fruits,” says Maria Bottazzi, a microbiologist who co-directs the Texas Children’s Hospital Center for Vaccine Development. But other types, like live attenuated viral vaccines, are especially susceptible to changes in temperature. Diverse approaches are necessary, she says: “There’s no silver bullet.”
But even if technical hurdles are overcome, getting temperature-stable formulations to market requires “aligning all the stars,” for manufacturers and regulators, Bottazzi says.
https://www.sciencemag.org/news/2021/04/here-s-how-scientists-are-designing-vaccines-can-ditch-fridge
April 21, 2021.
New cancer therapy: with electrospray against lung tumors
April 27, 2021
"Swiss research team has now succeeded in developing a special therapy that is supposed to counteract the aggressive tumors."
"the research team has already initiated the necessary steps for a clinical investigation."
"The electrospray technology is very promising and can be used for targeted chemotherapy, Gene therapy and immunotherapy can be used. In addition, with a few design changes, it can be used in various organs, both externally and for internal visceral organs, ”say the study authors.
Dr. Amiq Gazdhar notes: “We had assumed that electrospray directly on the tumor would give good results. But the extent of the reduction of over four fifths surprised us. "
https://healthnewsnet.de/news-2/neue-krebstherapie-mit-elektrospray-gegen-lungentumore-22170/
Mymetics assigned Electrospray patent created by Gerd and Rinaldo:
US20040175392A1
https://patents.google.com/patent/US20040175392A1/en
Super Mario!
https://www.pneumologie.dbmr.unibe.ch/research/group_blank/collaborators/
https://www.pneumologie.dbmr.unibe.ch/research/group_blank/
Plenty of familiar names, collaborators within each group inside link (Dr. Gazdhar, Geiser, Blank etc.)
Electrospray Mediated Localized and Targeted Chemotherapy in a Mouse Model of Lung Cancer
Dr.Amiq Gazdhar. Dr. Thomas Geiser. April 20, 2021
https://www.frontiersin.org/articles/10.3389/fphar.2021.643492/full
Electrospray with virosomes again with Gerd and Rinaldo (December 18,2020)
https://journals.asm.org/doi/10.1128/IAI.71.8.4749-4758.2003
Mymetics assigned Electrospray patent created by Gerd and Rinaldo:
US20040175392A1
https://patents.google.com/patent/US20040175392A1/en
https://www.mymetics.com/media-center/mymetics-advance-preclinical-studies-virosome-based-covid-19-vaccine-through-innosuisse-grant/
University of Bern, Volker Thiel update.
Scientists Have Discovered an Achilles Heel of the Coronavirus
JUNE 9, 2021.
https://scitechdaily.com/scientists-have-discovered-an-achilles-heel-of-the-coronavirus/
https://twitter.com/profvolkerthiel?lang=en
Fruci & Associates Ii, LLC is a Nebraska Foreign Professional LLC filed On January 12, 2018.
Filing State: Nebraska (NE)
Domestic State: Washington (WA)
Filing Status: Active
https://www.bizapedia.com/ne/fruci-and-associates-ii-llc.html
Thank you Siar! Réduit Suisse strategy employed in multiple facets here.
I hope life is well.
It appears Merck and its subsidiary, Themis Biosciences are making strides on Chikugunya with their v-184 vaccine.
https://www.clinicaltrialsarena.com/comment/mercks-chikungunya-fever-vaccine-trial-sees-11-point-spike-in-chances-to-transition-to-next-stage/
June 18, 2021.
"Who looks outside, dreams; who looks inside, awakes." -Carl Gustav Jung
Beth-Ann Coller, Merck's Global Executive Director, Clinical Development Vaccines has a virosome patent.
European Patent Office: EP1755666B1
https://patents.google.com/patent/EP1755666B1
This scientist helps translate inventions into vaccines to protect public health
https://www.merck.com/stories/this-scientist-helps-translate-inventions-into-vaccines-to-protect-public-health/
February 24, 2021.
Ulrich Burkhard is hiring a compliance officer.
Start of work: Immediately, no later than October 1, 2021.
https://www.marcuardfamilyoffice.com/news/compliance-officer-mind-80/
June 21, 2021.
Interesting timing with Mymetics changing to Fruci & Associates for accounting on June 17, 2021.
https://sec.report/Document/0001654954-21-006990/
Congratulations to Dr. Mai-Britt Zocca!
Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca
Mai-Britt Zocca, PhD, is Founder and CEO of IO Biotech.
IO Biotech and MYMX are currently in an exploratory project.
https://www.valotx.com/article/valo-therapeutics-announces-board-appointment-dr-mai-britt-zocca
https://www.valotx.com/
https://www.mymetics.com/media-center/exploratory-project-compare-io-biotech-antigens-linked-mymetics-virosomes-preclinical-tumor-model/
Mr. Kempers filed liquidation as CEO of Renewave Medical Systems.
On 10.11.2008, the following mutation was published in the SOGC about the company Renewave Medical Systems SA en liquidation, Nyon. It concerns the company ID CH-550.1.040.265-7 and was published in the swiss commercial register / SOGC.
He was the CEO of Renewave Medical Systems from 2006-2008.
https://sogc.help.ch/publ.cfm?key=217859
Mr. Kempers then joined Mymetics as Chief Operating Officer in July 2009.
Prior to joining Mymetics in 2009, Mr. Kempers lead the "restructuring" of an innovative Swiss medical device company as the CEO.(Renewave Medical Systems)
Liquidation is a form of restructuring.
https://www.sec.gov/Archives/edgar/data/927761/000095012310075718/l40498exv99w1.htm
Don't know the facts that led to prior liquidation but MYMX insider's thought enough to hire Mr. Kempers a year after and then promote him to CEO.
FYI: MYMX pps averaged around $0.15 over a decade ago in the month when he was hired.(July 2009).
Leave poor ole Kempers alone.
If the insider's spent 1/10 of the time on Mymetics as they do with yachting, art and uptownBasel this stock would already be uplisted.
Energy vampire until proven otherwise.
https://me.me/i/believe-in-yourself-especially-whern-o-one-else-will-sasquatch-b572a6735819444a90a562600cdd00ba
Virosome Vaccine against Newcastle Disease in Pakistan
2021.
https://www.hindawi.com/journals/bmri/2021/8879277/
34,386 Total Shares Traded This Week.
Forensic pathologist is circling Biopole looking for a parking place.
Refresh Copenhagen: Fireside Chat with Mai-Britt Zocca, CEO and Founder of IO Biotech
Nov 8, 2019.
28:15
Mymetics collaboration with IO Biotech began in May 25, 2020.
Greetings from Seattle's KEXP.
Dr. Doriana Fruci
Department of Hematology/Oncology and Gene and Cell Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
http://www.capstone-etn.eu/web/capstone-etn/1011306087/list1187970090/f1.html
https://www.researchgate.net/profile/Doriana-Fruci
Hope springs eternal.
Keep your fingers crossed.
Just avoid your company from being delisted and you too can obtain a coveted, non executive director's gig.
No accountability mirror.
Interesting wiki page that you included.
Center for Vaccinology (CEVAC) at the University of Ghent (Belgium) is where Mymetics HIV showed strong preliminary Phase I data over a decade ago.
Did you puddle jump over to visit Fruci in Spokane yet? 47.6588N, 117.4260W
Is intranasal drug delivery the best way to administer COVID-19 therapeutics?
https://www.europeanpharmaceuticalreview.com/article/141663/is-intranasal-drug-delivery-the-best-way-to-administer-covid-19-therapeutics/
Webinar: Variable pathlength spectroscopy for dilution-free concentration measurement in GMP environments
DATE: 24 JUNE | TIME: 15:00 BST
Lymphocytes upregulate CD36 in adipose tissue and liver
Dr. Ruth Ruprecht and Dr. Samir Lakhashe. 2019.
https://www.aminer.org/pub/5cc987c6e1cd8e57f54393ce/lymphocytes-upregulate-cd-in-adipose-tissue-and-liver
Ruprecht had Lakhashe working on the HIV vaccine with her in 2016 per article. They've collaborated for over a decade together.
https://sanantonioreport.org/texas-biomed-receives-23-million-to-develop-hiv-vaccine/
Samir K. Lakhashe works for the National Aids Research Institute out of Pune, India.
https://www.aminer.org/profile/samir-k-lakhashe/53f46442dabfaee43ecee47e
Dr. Ramya Dwivedi,Biotechnology from the National Chemical Laboratories (CSIR-NCL), authored the April 2021 article, "Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?"
https://www.news-medical.net/news/20210420/Could-virosome-based-nanovaccines-be-a-promising-new-approach-to-preventing-viral-diseases.aspx
Dr. Samir K. Lakhashe and Dr. Ramya Dwivedi are both from Pune, India.
Dr. Antonio Lanzavecchia had been working with Dr. Ruth Ruprecht per
2016 article on Mymetics HIV vaccine.
https://sanantonioreport.org/texas-biomed-receives-23-million-to-develop-hiv-vaccine/
Dr. Antonio Lanzavecchia then gets hires as Senior VP for Vir Biotechnology in 2017.
https://www.businesswire.com/news/home/20171218005435/en/Vir-Biotechnology-Appoints-Leading-Immunologist-Antonio-Lanzavecchia-M.D.-Senior-Vice-President-Senior-Research-Fellow
Dr. Antonio Lanzavecchia collaborates with GSK and recieves FDA emergency use authorization for Sotrovimab (VIR-7831)
https://www.globenewswire.com/news-release/2021/05/26/2236926/0/en/GSK-and-Vir-Biotechnology-Announce-Sotrovimab-VIR-7831-Receives-Emergency-Use-Authorization-from-the-US-FDA-for-Treatment-of-Mild-to-Moderate-COVID-19-in-High-Risk-Adults-and-Pedia.html
Why didn't Dr. Staehelin hire Dr. Antonio Lanzavecchia?